Stanley Laman Group, Ltd. Sanofi Transaction History

Stanley Laman Group, Ltd.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$45.3 - $51.62 $1.7 Million - $1.94 Million	-37,523 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$49.47 - $53.77 $160,925 - $174,913	3,253 Added 9.49%	37,523 $1.88 Million
Q2 2020 Jul 20, 2020	BUY	$42.91 - $52.5 $2,789 - $3,412	65 Added 0.19%	34,270 $1.75 Million
Q1 2020 May 12, 2020	SELL	$38.02 - $51.66 $63,683 - $86,530	-1,675 Reduced 4.67%	34,205 $1.5 Million
Q4 2019 Feb 04, 2020	SELL	$44.25 - $50.86 $95,093 - $109,298	-2,149 Reduced 5.65%	35,880 $1.8 Million
Q3 2019 Nov 08, 2019	SELL	$40.34 - $46.64 $17,547 - $20,288	-435 Reduced 1.13%	38,029 $1.76 Million
Q2 2019 Aug 01, 2019	SELL	$40.43 - $44.3 $9,501 - $10,410	-235 Reduced 0.61%	38,464 $1.66 Million
Q1 2019 May 10, 2019	SELL	$40.83 - $45.43 $27,151 - $30,210	-665 Reduced 1.69%	38,699 $1.71 Million
Q4 2018 Feb 07, 2019	SELL	$41.48 - $45.59 $124,481 - $136,815	-3,001 Reduced 7.08%	39,364 $1.71 Million
Q3 2018 Oct 30, 2018	SELL	$40.0 - $44.84 $34,920 - $39,145	-873 Reduced 2.02%	42,365 $1.89 Million
Q2 2018 Aug 09, 2018	SELL	$37.63 - $41.22 $145,891 - $159,809	-3,877 Reduced 8.23%	43,238 $1.73 Million
Q1 2018 May 01, 2018	SELL	$38.98 - $45.76 $135,884 - $159,519	-3,486 Reduced 6.89%	47,115 $1.89 Million
Q4 2017 Feb 09, 2018	BUY	$42.86 - $50.61 $78,819 - $93,071	1,839 Added 3.77%	50,601 $2.18 Million
Q3 2017 Nov 13, 2017	BUY	$47.04 - $50.34 $2.29 Million - $2.45 Million	48,762	48,762 $2.43 Million

807

270M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $134B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Stanley Laman Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stanley Laman Group, Ltd. with notifications on news.